Beth Young Karlan is an American gynecologic oncologist. In 2008, she was named editor-in-chief of the medical journals Gynecologic Oncology and Gynecologic Oncology Reports. In 2012, Karlan was appointed by the White House to serve on the National Cancer Advisory Board, and in 2015, she was elected to the National Academy of Medicine. Karlan is best known for her clinical efforts in identifying, treating, and preventing ovarian cancer, and her research focuses on inherited cancer risk, specifically cancers related to BRCA1/2 mutations. Her research has identified subtype-specific biomarkers for early detection, prognostication, and personalized therapies in gynecologic malignancies. Source: Wikipedia (en)